VRDN
VRDN
US92790C1045
Viridian Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.11B EUR
2.08B EUR
2B EUR
3.17B EUR
Enterprise Value
1.44B EUR
2.16B EUR
1.88B EUR
3.01B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-6.81x
--
--
--
Price to Sales
29.72x
29.25x
28.26x
44.77x
Price to Book
3.75x
3.14x
3.15x
4.39x
EV/Revenue
20.23x
30.34x
26.49x
42.49x
EV/EBITDA
-3.56x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-13.03%
-16.11%
-15.16%
-5.81%
ende